These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 24008687)

  • 1. The neuroprotection of liraglutide on Alzheimer-like learning and memory impairment by modulating the hyperphosphorylation of tau and neurofilament proteins and insulin signaling pathways in mice.
    Xiong H; Zheng C; Wang J; Song J; Zhao G; Shen H; Deng Y
    J Alzheimers Dis; 2013; 37(3):623-35. PubMed ID: 24008687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dulaglutide ameliorates STZ induced AD-like impairment of learning and memory ability by modulating hyperphosphorylation of tau and NFs through GSK3β.
    Zhou M; Chen S; Peng P; Gu Z; Yu J; Zhao G; Deng Y
    Biochem Biophys Res Commun; 2019 Mar; 511(1):154-160. PubMed ID: 30773255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liraglutide Improves Water Maze Learning and Memory Performance While Reduces Hyperphosphorylation of Tau and Neurofilaments in APP/PS1/Tau Triple Transgenic Mice.
    Chen S; Sun J; Zhao G; Guo A; Chen Y; Fu R; Deng Y
    Neurochem Res; 2017 Aug; 42(8):2326-2335. PubMed ID: 28382596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous administration of liraglutide ameliorates Alzheimer-associated tau hyperphosphorylation in rats with type 2 diabetes.
    Yang Y; Zhang J; Ma D; Zhang M; Hu S; Shao S; Gong CX
    J Alzheimers Dis; 2013; 37(3):637-48. PubMed ID: 23948890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early intervention with glucagon-like peptide 1 analog liraglutide prevents tau hyperphosphorylation in diabetic db/db mice.
    Ma DL; Chen FQ; Xu WJ; Yue WZ; Yuan G; Yang Y
    J Neurochem; 2015 Oct; 135(2):301-8. PubMed ID: 26183127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3β pathway in an amyloid β protein induced alzheimer disease mouse model.
    Qi L; Ke L; Liu X; Liao L; Ke S; Liu X; Wang Y; Lin X; Zhou Y; Wu L; Chen Z; Liu L
    Eur J Pharmacol; 2016 Jul; 783():23-32. PubMed ID: 27131827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (Val⁸) glucagon-like peptide-1 prevents tau hyperphosphorylation, impairment of spatial learning and ultra-structural cellular damage induced by streptozotocin in rat brains.
    Li L; Zhang ZF; Holscher C; Gao C; Jiang YH; Liu YZ
    Eur J Pharmacol; 2012 Jan; 674(2-3):280-6. PubMed ID: 22115895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
    McClean PL; Hölscher C
    Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal insulin ameliorates tau hyperphosphorylation in a rat model of type 2 diabetes.
    Yang Y; Ma D; Wang Y; Jiang T; Hu S; Zhang M; Yu X; Gong CX
    J Alzheimers Dis; 2013; 33(2):329-38. PubMed ID: 22936005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin and its metabolite N(1)-acetyl-N(1)-formyl-5-methoxykynuramine improve learning and memory impairment related to Alzheimer's disease in rats.
    Rong K; Zheng H; Yang R; Liu X; Li L; Chen N; Zhao G; Gong C; Deng Y
    J Biochem Mol Toxicol; 2020 Feb; 34(2):e22430. PubMed ID: 31833155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects.
    Palleria C; Leo A; Andreozzi F; Citraro R; Iannone M; Spiga R; Sesti G; Constanti A; De Sarro G; Arturi F; Russo E
    Behav Brain Res; 2017 Mar; 321():157-169. PubMed ID: 28062257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silibinin ameliorates STZ-induced impairment of memory and learning by up- regulating insulin signaling pathway and attenuating apoptosis.
    Liu P; Cui L; Liu B; Liu W; Hayashi T; Mizuno K; Hattori S; Ushiki-Kaku Y; Onodera S; Ikejima T
    Physiol Behav; 2020 Jan; 213():112689. PubMed ID: 31669775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical ocular administration of the GLP-1 receptor agonist liraglutide arrests hyperphosphorylated tau-triggered diabetic retinal neurodegeneration via activation of GLP-1R/Akt/GSK3β signaling.
    Shu X; Zhang Y; Li M; Huang X; Yang Y; Zeng J; Zhao Y; Wang X; Zhang W; Ying Y
    Neuropharmacology; 2019 Jul; 153():1-12. PubMed ID: 31015047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liraglutide Ameliorates Hyperhomocysteinemia-Induced Alzheimer-Like Pathology and Memory Deficits in Rats via Multi-molecular Targeting.
    Zhang Y; Xie JZ; Xu XY; Hu J; Xu T; Jin S; Yang SJ; Wang JZ
    Neurosci Bull; 2019 Aug; 35(4):724-734. PubMed ID: 30632006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xanthoceraside attenuates learning and memory deficits via improving insulin signaling in STZ-induced AD rats.
    Liu P; Zou L; Jiao Q; Chi T; Ji X; Qi Y; Xu Q; Wang L
    Neurosci Lett; 2013 May; 543():115-20. PubMed ID: 23562514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy.
    Popelová A; Pražienková V; Neprašová B; Kasperová BJ; Hrubá L; Holubová M; Zemenová J; Blum D; Železná B; Galas MC; Kuneš J; Maletínská L
    J Alzheimers Dis; 2018; 62(4):1725-1736. PubMed ID: 29614684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of mTORC1 improves STZ-induced AD-like impairments in mice.
    Cao Y; Liu B; Xu W; Wang L; Shi F; Li N; Lei Y; Wang J; Tian Q; Zhou X
    Brain Res Bull; 2020 Sep; 162():166-179. PubMed ID: 32599128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Geniposide ameliorates learning memory deficits, reduces tau phosphorylation and decreases apoptosis via GSK3β pathway in streptozotocin-induced alzheimer rat model.
    Gao C; Liu Y; Jiang Y; Ding J; Li L
    Brain Pathol; 2014 Apr; 24(3):261-9. PubMed ID: 24329968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anorexigenic lipopeptides ameliorate central insulin signaling and attenuate tau phosphorylation in hippocampi of mice with monosodium glutamate-induced obesity.
    Špolcová A; Mikulášková B; Holubová M; Nagelová V; Pirnik Z; Zemenová J; Haluzík M; Železná B; Galas MC; Maletínská L
    J Alzheimers Dis; 2015; 45(3):823-35. PubMed ID: 25624414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liraglutide Suppresses Tau Hyperphosphorylation, Amyloid Beta Accumulation through Regulating Neuronal Insulin Signaling and BACE-1 Activity.
    Jantrapirom S; Nimlamool W; Chattipakorn N; Chattipakorn S; Temviriyanukul P; Inthachat W; Govitrapong P; Potikanond S
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32138327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.